Bgm (BGM) Income towards Parent Company (2019 - 2025)

Bgm's (BGM) quarterly Income towards Parent Company came in at $182.1 million in Q1 2025, up 319.33% year-on-year from $43.4 million in Q1 2024, and up 326.08% on a QoQ basis from $42.7 million in Q3 2024.

Bgm (BGM) Income towards Parent Company (2019 - 2025) Analysis & Trends

Bgm (BGM) has 7 years of Income towards Parent Company data on file, last reported at $182.1 million in Q1 2025.

  • On a quarterly basis, Income towards Parent Company rose 319.33% year-over-year to $182.1 million in Q1 2025; TTM through Mar 2025 was $182.1 million, a 319.33% increase from a year earlier, with the FY2025 full-year figure at -$20.0 million, down 146.9% from the prior year.
  • Income towards Parent Company for Q1 2025 stood at $182.1 million, up from $42.7 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for BGM reached as high as $55477.7 billion in Q1 2022 and fell as low as $42.7 million in Q3 2024.
  • Historically, Income towards Parent Company has averaged $27029.3 billion across 5 years, with a median of $26423.0 billion in 2023.
  • Across the five-year window, Income towards Parent Company soared 210200352.64% in 2021 and plunged 100.0% in 2023, its largest moves.
  • Year by year, Income towards Parent Company stood at $54858.6 billion in 2021, then dropped by 3.29% to $53052.1 billion in 2022, then plunged by 100.0% to $42.8 million in 2023, then slipped by 0.11% to $42.7 million in 2024, then surged by 326.08% to $182.1 million in 2025.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $182.1 million in Q1 2025, $42.7 million in Q3 2024, and $43.4 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Bgm 33.55 Mn 23.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 182.12 Mn
Sep 30, 2024 42.74 Mn
Mar 31, 2024 43.43 Mn
Sep 30, 2023 42.79 Mn
Mar 31, 2023 52,845.84 Bn
Sep 30, 2022 53,052.14 Bn
Mar 31, 2022 55,477.71 Bn
Sep 30, 2021 54,858.61 Bn
Sep 30, 2020 26.10 Mn
Sep 30, 2019 19,893.35 Bn